More than a decade after the FDA dissolved its advisory committee on pharmacy compounding, the agency has resurrected the panel – although, this time with some new members, whose identities were revealed on 16 December.
The FDA's new Pharmacy Compounding Advisory Committee, which consists of 14 members – 12 voting and two non-voting –...